◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF Overview
Price history, fund statistics and profile — an exchange-traded fund.
Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund managed by Virtus in the "Health" category. It manages roughly $46 million in assets.
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S.
Interactive chart & fund stats →
BBC Fund Statistics
| Expense ratio | 0.65% |
| Trailing yield | 1.34% |
| Assets under management | $46 million |
| Fund category | Health |
| Fund family | Virtus |
| Inception | 2014-12-16 |
The live price chart, fund profile and news are in the interactive BBC viewer.
Other Companies in Health
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.